title: Resolution of marked intrapartum fetal tachycardia following intravenous nalbuphine hydrochloride.
abstract: We report a case of a patient who received nalbuphine during labor. The fetus was in an awake state, but when exposed to intravenous nalbuphine manifested quiet sleep. This suggest a physiological response and not a sign of fetal compromise.
authors.affiliation: Department of Obstetrics & Gynecology, Strong Memorial Hospital, University of Rochester School of Medicine and Dentistry, New York.
authors.forename: D M
authors.initials: DM
authors.lastname: Sherer
authors.forename: E M
authors.initials: EM
authors.lastname: Cooper
authors.forename: C
authors.initials: C
authors.lastname: Spoor
authors.forename: B L
authors.initials: BL
authors.lastname: Serletti
authors.forename: J R
authors.initials: JR
authors.lastname: Woods
mesh_terms: D000293:Adolescent; D016362:Analgesia, Obstetrical; D005260:Female; D005324:Fetal Movement / Q000187:drug effects; D006340:Heart Rate, Fetal / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D007743:Labor, Obstetric; D009266:Nalbuphine / Q000627:therapeutic use*; D011247:Pregnancy
chemical_list: D009266:Nalbuphine